Clinical trial
Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in…
NCT00309491 · Austrian Breast & Colorectal Cancer Study Group, Other · Completed
Key facts
| NCT number | NCT00309491 |
|---|---|
| Title | Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients |
| Official title | A Randomized Phase III Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal, Hormone Receptor-positive Patients |
| Lead sponsor | Austrian Breast & Colorectal Cancer Study Group, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Early-stage Breast Cancer |
| Intervention type | Drug |
| Interventions | Tamoxifen alone, Tamoxifen + Aminoglutethimide |
| Enrollment | 2,021 |
| Start date | Dec 1, 1990 |
| Primary completion | Jan 1, 1996 |
| Completion | Mar 1, 2000 |
| First posted | Apr 3, 2006 |
| Last update posted | Oct 19, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: